Our study revealed that the inhibition of PLP2 could suppress cyclin-B, cyclin-E, and CDK1 expression in LN229 glioma cells (** p < 0.01; *** p < 0.001, Figure 5C). Here, CCNE1 is linked to central nervous system cancer.